Global Our mission Advancing innovation to improve lives Therapeutic areas FIND OUT MORE Contract Manufacturing FIND OUT MORE R&D FIND OUT MORE Patients FIND OUT MORE About us Learn how we've been delivering on our mission for patients for 90 years. Media RIEMSER BECOMES ESTEVE GERMANY WITH A NEW MANAGING DIRECTOR, KLAUS SCHWARZ RIEMSER Pharma GmbH has been part of the international pharma company ESTEVE since last year, and now officially becomes ESTEVE Pharmaceuticals GmbH: a different brand but the... 16/11/2021 Read more ESTEVE ANNOUNCES FDA APPROVAL OF A NOVEL CO-CRYSTAL FORM OF CELECOXIB AND TRAMADOL FOR THE MANAGEMENT OF ACUTE PAIN This marks the first proprietary research product from ESTEVE to be approved in the United States 18/10/2021 Read more FOLLOWING IN THE WAKE OF COVID-19, MYOPIA WILL BE THE NEXT PANDEMIC TO EMERGE, ESPECIALLY AMONG CHILDREN AND YOUNG PEOPLE According to the WHO, the increased use of screens and lack of natural light are leading to an increase in myopia among children. If the trend continues, in 30 years' time 50%... 14/10/2021 Read more Our global presence An european specialty pharma company with sales across the world. Discover Get our latest news and media resources Go About us Who we are Corporate governance Our global presence Our commitment Therapeutic areas Contract Manufacturing R&D Research Areas Pipeline Scientific publications Patients B2B Partnering Media Corporate resources Contact Adverse reactions Work with us Privacy Legal notice Cookies policy Last update 11/11/2021 | © 1996-2021 ESTEVE Use of cookies We use our own and third-party cookies for analytic, technical and profiling purposes; we process data that is needed to create profiles based on your browsing habits. Press the "ACCEPT COOKIES" button to confirm their use. You can change the configuration of your cookies by pressing "MORE INFORMATION AND CONFIGURATION". ACCEPT COOKIES MORE INFORMATION AND CONFIGURATION * *This option allows you to reject the cookies.